Accendra Health, Inc. (ACH)
NYSE: ACH · Real-Time Price · USD
0.2047
-0.0934 (-31.33%)
At close: Nov 6, 2026, 4:00 PM EST
0.2151
+0.0104 (5.08%)
After-hours: Nov 6, 2026, 7:40 PM EST

Accendra Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-171.56-1,101-362.69-41.322.39221.59
Depreciation & Amortization
230.9214.52181.28210.37214.6780.32
Other Amortization
----1410.3
Loss (Gain) From Sale of Assets
-108.1-27.27-35.36-34.88-26.26-
Asset Writedown & Restructuring Costs
--307.11---
Stock-Based Compensation
12.9612.8716.6414.420.9925.02
Provision & Write-off of Bad Debts
-----21.16
Other Operating Activities
-1.29989.8114.150.44-13.8727.19
Change in Accounts Receivable
95.41122.36-3.68-8.994.42-2.2
Change in Inventory
-20.58-6.85-4.59-5.35166.56-263.44
Change in Accounts Payable
55.546.4866.895.2513.653.55
Change in Other Net Operating Assets
-51.98-56.78-36.03146.53-91.540.69
Operating Cash Flow
-25.31-101.79161.5740.71325.01124.18
Operating Cash Flow Growth
---78.20%127.91%161.73%-63.39%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-173.81-190.96-170.29-172.38-158.09-40.99
Sale of Property, Plant & Equipment
149.6477.9769.9371.5748.38-
Cash Acquisitions
-----1,685-
Divestitures
324.26324.26----
Sale (Purchase) of Intangibles
-5.88-10.37-12.38-6.16-8.49-8.71
Other Investing Activities
19.24-56.48-3.79-30.3-1.67-3.94
Investing Cash Flow
313.45144.42-116.53-137.25-1,804-53.63

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-2,9152,1024762,743574.9
Long-Term Debt Repaid
--2,711-2,346-892.69-1,161-656.34
Net Debt Issued (Repaid)
-235.7203.5-244.2-416.691,583-81.44
Repurchase of Common Stock
-3.52-10.18----
Common Dividends Paid
------0.73
Other Financing Activities
-68.57-5.24-23.41-0.64-85.4-47.31
Financing Cash Flow
-307.79188.08-267.6-417.331,497-129.48

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.091.9-0.90.61-3.49-3.54
Net Cash Flow
-19.56232.61-223.54186.7414.15-62.47

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-199.12-292.75-8.79568.34166.9283.19
Free Cash Flow Growth
---240.49%100.64%-71.19%
Free Cash Flow Margin
-7.80%-10.60%-0.33%22.26%1.68%0.85%
Free Cash Flow Per Share
-2.60-3.81-0.127.352.191.10
Levered Free Cash Flow
309.24671.6896.36563.85395.04102.03
Unlevered Free Cash Flow
396.2742.85163.59636.83475.6132.08

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
128.76134.71141.55153.25107.0238.72
Cash Income Tax Paid
25.2912.475.55-6.2833.9799.4
Change in Working Capital
78.3865.2122.6137.4393.08-261.4